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Abstract
AIM: To review the use of the Months Backwards Test 
(MBT) in clinical and research contexts.
METHODS: We conducted a systematic review of 
reports relating to the MBT based upon a search of 
PsychINFO and MEDLINE between January 1980 and 
December 2014. Only reports that specifically described 
findings pertaining to the MBT were included. Findings 
were considered in terms of rating procedures, testing 
performance, psychometric properties, neuropsychological 
studies and use in clinical populations.
RESULTS: We identified 22 data reports. The MBT is 
administered and rated in a variety of ways with very 
little consistency across studies. It has been used to 
assess various cognitive functions including focused 
and sustained attention as well as central processing 
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speed. Performance can be assessed in terms of the 
ability to accurately complete the test without errors 
(“MB accuracy”), and time taken to complete the test 
(“MB duration”). Completion time in cognitively intact 
subjects is usually < 20 s with upper limits of 60-90 s 
typically applied in studies. The majority of cognitively 
intact adults can complete the test without error such 
that any errors of omission are strongly suggestive of 
cognitive dysfunction. Coverage of clinical populations, 
including those with significant cognitive difficulties is 
high with the majority of subjects able to engage with 
MBT procedures. Performance correlates highly with 
other cognitive tests, especially of attention, including 
the digit span backwards, trailmaking test B, serial 
threes and sevens, tests of simple and complex choice 
reaction time, delayed story recall and standardized list 
learning measures. Test-retest and inter-rater reliability 
are high (both > 0.90). Functional magnetic resonance 
imaging studies comparing the months forward test 
and MBT indicate greater involvement of more complex 
networks (bilateral middle and inferior frontal gyri, the 
posterior parietal cortex and the left anterior cingulate 
gyrus) for backwards cognitive processing. The MBT 
has been usefully applied to the study of a variety of 
clinical presentations, for both cognitive and functional 
assessment. In addition to the assessment of major 
neuropsychiatric conditions such as delirium, dementia 
and Mild Cognitive Impairment, the MBT has been 
used in the assessment of concussion, profiling of 
neurocognitive impairments in organic brain disorders 
and Parkinson’s disease, prediction of delirium risk in 
surgical patients and medication compliance in diabetes. 
The reported sensitivity for acute neurocognitive 
disturbance/delirium in hospitalised patients is estimated 
at 83%-93%. Repeated testing can be used to identify 
deteriorating cognitive function over time.
CONCLUSION: The MBT is a simple, versatile tool 
that is sensitive to significant cognitive impairment. 
Performance can be assessed according to accuracy and 
speed of performance. However, greater consistency in 
administration and rating is needed. We suggest two 
approaches to assessing performance - a simple (pass/
fail) method as well as a ten point scale for rating test 
performance (467).
Key words: Cognition; Assessment; Months backward 
test; Delirium; Dementia
© The Author(s) 2015. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: The months backward test is a brief test of 
cognitive function that is commonly used in clinical 
practice. It provides a convenient test of central proce-
ssing speed and both focused and sustained attention. 
This review of studies reporting its use in clinical 
populations identified many different approaches to 
administration and interpretation of the test. Overall, 
cognitively intact adults can complete the test within 60 
s without omission errors, such that failure to achieve 
this is strongly suggestive of cognitive dysfunction. The 
sensitivity for neurocognitive disturbance in hospitalised 
patients is 83%-93% and repeated testing can identify 
deteriorating cognitive function over time.
Meagher J, Leonard M, Donoghue L, O’Regan N, Timmons S, 
Exton C, Cullen W, Dunne C, Adamis D, Maclullich AJ, Meagher 
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INTRODUCTION
The months backwards test (MBT), also known as 
the months of the year in reverse order (MOYR) test 
is a rapid (< 2 min) and simple to administer test of 
cognitive function that is widely used at the bedside. It 
has been described as primarily a test of attention[1-3], 
as well as a test of concentration[4], working memory, 
executive function[5,6], cognitive flexibility[7] and central 
processing speed[8]. The MBT has been applied to study 
cognitive function in Parkinson’s disease[9], to stage 
dementia[10-12], assess concussion in sports[13-15], predict 
medication adherence in patients with diabetes[6], 
and predict delirium risk[5]. The MBT has particular 
utility in screening for delirium and related disorders in 
hospitalised patients[16-18]. 
We conducted a review of the test to determine: 
(1) the ways in which is administered and rated; (2) 
its psychometric properties, including comparison with 
other simple bedside tests of cognition; and (3) findings 
from its use in clinical and research studies. 
MATERIALS AND METHODS
We searched PsychINFO and MEDLINE for papers 
reporting the use and characteristics of the MBT, sear-
ching from 1980 onwards using the search terms 
“Months reverse” or “months backward” and “test”, with 
human and English language limits. Because the MBT 
is a component of several composite test batteries, 
the review was limited to reports where the MBT was 
described separately, so that its application and findings 
could be individually reported.
“Months reverse” or “months backward” and “test” 
with English language limits identified 502 articles of 
which 17 were relevant to the review. Additional articles 
(n = 5) were identified by reviewing the references 
of these reports and checking for similar work by the 
authors and subsequent citations (Figure 1).
RESULTS
The 22 articles identified included descriptions of various 
ways that the test has been applied (including testing 
procedures and interpretation of test performance), 
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psychometric properties, and findings in a variety of 
different populations. 
Testing procedures
The test requests the subject to recite the months of 
the year in reverse order starting with December, then 
November, then October and so on, until the subject 
reaches January or cannot continue. Some variants 
require the patient to reach a particular month (e.g., 
July) rather than recite all twelve. The test is often 
preceded by asking the patient to recite the months 
forwards, indicating their capacity to engage and 
understand simple commands (i.e., basic contextual 
awareness). In the reviewed papers, the MBT was 
mostly conducted at the bedside or in other routine 
clinical patient contacts (e.g., outpatient/memory clinic). 
It can be also be administered by telephone (Ball et al[8], 
1999) and versions are available in several languages. 
The test requires minimal formal training but must 
be explained clearly and logically to the subject (see 
Table 1 for an example of test introduction and pro-
cedures). Basic training for testers usually includes 
an explanation of procedures, followed by observing 
the test being performed, and then being observed 
conducting it, to ensure clarity of explanation and 
consistent administration and interpretation. However, 
training procedures are not addressed in most reports.  
Where the test is timed, the patient is often asked 
to recite the months as quickly as possible[19]. The task 
commences after the participant has confirmed that 
they have understood the instructions and are ready to 
start. There is less consistency as to how to respond to 
the patient who is struggling with the test in respect of 
prompting or re-orientating them to the test. Similarly, 
the number of discrete trials allowable to assess (best) 
performance is not consistently defined. It is common 
for the rater to record the participant’s responses month 
by month to include omissions and commissions, as well 
as pauses (denoted by an underscore that corresponds 
with the duration of delay).
The test typically takes 1-2 min, with cognitively 
intact patients usually completing the test within 20 s[19]. 
Cut off times for completion of 60[20], 75[8], and 90 s[21] 
have been suggested to define an upper limit above 
which patients cannot successfully complete the test. 
Rating of performance
Table 2 details the approaches to MBT scoring adopted 
in the studies included in this review. Performance 
can be assessed in two ways: (1) ability to accurately 
complete the test without errors (“MB accuracy”); and 
(2) time taken to complete the test (“MB duration”). 
Most subjects under 65 years of age can readily 
complete the test without error[14,19,20], and therefore the 
duration to complete the test is more useful (measuring 
central processing speed) in younger populations. 
“MB accuracy” assesses the capacity to complete 
the test, and how far subjects can reach without 
error and with/without prompting. Errors include: (1) 
omissions; (2) perseverations or stuttered responses 
(e.g., “September… September…August, July”); and (3) 
Commissions such as false positive errors (i.e., words 
that are relevant to the task but incorrect such as July 
where June should be) and intrusion errors involving 
words or phrases that are not related to the task[22]. 
In many cases, test performance is dichotimised into 
a positive or negative result according to specific criteria 
such as correctly reciting all months with minimal 
prompting (if under age 65 years) or reciting until July 
(if aged 65 or older)[16], completing either 7 consecutive 
correct iterations or 11 correct with no more than one 
mistake[20], omission of two or more months[21], or a 
total of two or more errors of any kind[7]. In other testing 
procedures, an ordinal scale of accuracy performance 
(ranging from 0-2) is used[9,23,24], while a continuous 
scale of accuracy performance can be established 
according to the total number of errors[19]. Lamar et 
al[25] used the Accuracy Index {= [1 - (false positive 
+ misses)/(number of possible correct)] × 100}. This 
algorithm yields a percentage score whereby patients 
obtaining a score of 100% correctly identified all targets 
without commissions or omissions.
“MB duration” assessment varies considerably 
across studies and reflects the impact of factors such as 
age, gender and educational level on performance[13,19]. 
The Wechsler Memory Scale - third edition (WMS-
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Pubmed search
 Key words "Months reverse" or "Months 
backward” and “Test"
 Human and English language limits
Published between 1980 and 2014
New data
MBT described independently
Additional articles identified by searching 
references + author check + citations 
Total number of articles included
502
17
5
22
Figure 1  Process of article selection. MBT: Months backwards test. 
Table 1  A scheme for administering the months backward 
test
  "Hello Mr X, My name is Y. If it is convenient, I would like for you to 
  help me with a simple test to assess your concentration
  Can I ask you to say the months of the year from start to finish in their 
  usual order, starting with January?.....
  Now, can I get you to say the months again but this time in reverse 
  order starting with December…."
  Where a patient becomes “lost” they may require prompting to re-
  orientate them to the test and if this is required it should be noted, e.g.,   
  what were we doing again? How far did you get to? So before October 
  would be?  
Meagher J et al . Review of the months backwards test
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Table 2  Clinical studies using the months backward test
  Ref. Population and study purpose Assessment of MBT performance
  Halstead[10,28] (1944) To develop a battery of tests for “senility” in 38 subjects, 20 with 
recognised dementia
Pass/fail according to capacity to recite months in reverse 
from December to January
  Young et al[20] (1997) To compare the performance of 522 uninjured high school athletes 
on three simple mental status tests that are commonly used on the 
sidelines for the evaluation of concussions
Participants were given 1-min time limits for each test, with 
passing defined as either 7 consecutive correct iterations or 
11 correct with one mistake
  Ball et al[8] (1999) To evaluate the efficacy and reliability of the time to recite the 
months of the year in reverse order as a simple measure of central 
processing speed in 120 community-dwelling women, aged 67-94
Timing of MBT performance commenced when the subject 
starts the sequence and continues regardless of omissions, 
juxtapositions, or corrections until the sequence is complete 
or 75 s has elapsed. Those unable to complete the sequence 
received a score of 75 s
  Wildgruber et al[34] 
  (1999)
Comparison of MBT vs MFT in respect of brain activation using 
fMRI in 18 neurologically normal subjects aged 19-36
Subjects silently recited the MFT and subsequently the MBT 
as fast as possible and continuously across the whole length 
of each activation period
  Ettlin et al[27] (2000) Developing a scale (The FLS) to distinguish patients with various 
Ornagic brain difficulties
MBT rated from 0-2 in respect of both (1) accuracy (1 point 
for > 1 error of any kind) and (2) 1 point if completion time > 
24 s
  Lamar et al[22] (2002) A comparison of the capacity to sustain mental set in participants 
with AD vs IVD vs a NC
An AcI was calculated using the following algorithm:
AcI = {1 - [(false positive + misses)/number of possible
correct]} × 100
This algorithm yielded a percentage score such that patients 
obtaining a score of 100% correctly identified all targets and 
made no false positive responses or misses
  Alderson et al[29] (2003) To develop a brief scale for assessing cognition in patients with TBI A 4 point scale was applied where 0 = unable to complete of 
≥ 2 errors; 1 = able to complete but with 2 errors; 2 = able to 
complete but with one error; 3 = completed without error
  Marinus et al[9] (2003) Development of a scale to assess cognition in PD. Eighty-five PD 
patients and 75 control subjects were assessed with a battery of 
tests of which the MBT was a significantly discriminating test of 
attention. Test–retest reliability was assessed in 30 patients after 6 
wk
Performance rated on a scale of 0-2 but unclear how these 
scores were attributed
  Rudolph et al[5] (2006) To determine the extent to which preoperative performance on tests 
of executive function and memory was associated with delirium 
after coronary artery bypass graft surgery
Pass/fail according to ability to successfully recite from 
December back to January
  Dubois et al[21] (2007) To develop consensus amongst an expert group regarding 
diagnostic procedures for PD dementia
Pass/fail according to ability to successfully recite from 
December back to January. An unsuccessful performance 
equated with omission of two or more months, incorrect 
sequencing of the months, or failure to complete the test 
within 90 s
  Ostberg et al[11] (2008) To explore the utility of the MBT in diagnosis of cognitive 
impairment in N = 234 memory clinic attenders with subjective 
cognitive impairments, mild cognitive impairment and AD
Participants recited the months in reverse chronological 
order as quickly as possible. Ability to conduct the test 
accurately and duration to task completion were measured 
  Shehata et al[14] (2009) To determine baseline symptom and neurocognitive norms in 260 
university athletes with and without concussion histories using the 
SCAT
Months in reverse order was assessed on a pass/fail basis 
where a subject passed if they were able to recite the 12 mo 
in reverse order with no mistakes. The test was considered a 
fail if any months were in the wrong order or missed
  Roca et al[24] (2010) Comparison of neuropsychological performance in patients with 
documented frontal lobe lesions (n = 15) vs matched neurologically 
unimpaired controls
The patient was asked to list the months of the year 
backwards, starting with December. If subjects made 
no errors, the score was 2; for one error, the score was 1; 
otherwise the score was 0
  Schneider et al[15] (2010) Assessing performance on tests of cognition in hockey players aged 
9-17 with and without a history of concussion
The MBT was conducted as part of the SCAT: Months in 
reverse order was assessed on a pass/fail basis where a 
subject passed if they were able to recite the 12 mo in reverse 
order with no mistakes
  Grober et al[6] (2011) Investigating for predictors of diabetes control in 169 elderly 
diabetics
A composite score was constructed with 5 levels based upon 
animal naming and MBT performance as completed without 
errors, uncorrected errors or failed test
  Östberg et al[19] (2012) Identification of adult norms and test-retest reliability for durational 
and response accuracy on the MBT in 216 neurologically intact 
adults (aged 18-88). A retest was conducted with 40 participants 
after 3 wk
Participants were instructed to recite the months in 
backward order as quickly as possible without making any 
errors. The duration from commencement to cessation was 
defined as the MB duration score. Any uncorrected sequence 
error was noted down, and the total number of errors was 
defined as the MB response accuracy score. Errors were 
taken to include omissions and transpositions. Repetitions 
were not scored as errors
  Jinguji et al[13] (2012) To determine baseline scores in cognitive performance domains 
among 214 high school athletes with no prior history of a 
concussion
Ability to recite the months of the year in reverse order to 
January
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III)[23] identifies four levels of performance - 0 (> 17 s), 
1 (12-16 s), 2 (10-11 s), and 3 (1-9 s). Weintraub[26] 
suggests a performance cut off of 16 s while Ball et 
al[8] rated performance on a time continuum up to 
a predetermined limit of 75 s, with those unable to 
complete the sequence allocated a score of 75 s and no 
consideration given to errors. In other work, time limits 
of 60 s[20] and 90 s[21] have been applied.
Other work has combined accuracy (1 point for > 
1 error of any kind) and speed of completion (1 point 
if completion time > 24 s) to rate performance on an 
ordinal scale (0, 1, 2)[27].
Performance in different populations
Studies have explored MBT performance in various 
populations, including examining the impact of age, 
gender and educational level upon results. Typically, the 
MBT takes twice as long as reciting the MF in cognitively 
intact persons, although this distinction is increased in 
subjects with mild cognitive impairment or established 
dementia[11]. Halstead[28] in a seminal paper cited the 
discrepancy between forwards and backwards test 
performance as evidence of “senile inelasticity” and a 
reduced capacity to inhibit the impulse to recite well 
established patterns in their (usual) forwards manner. In 
general, the MBT is a simple test that most participants 
can complete without error, so that being unable to 
perform the task is unusual in younger adults and in 
these populations is a sensitive indicator of impairment. 
Indeed, as response accuracy is so high, the MBT has 
primarily been used to test processing speed test in 
cognitively intact individuals.
Successful completion rates for the MBT have been 
reported for a range of populations. Young et al[20] found 
89% of high school student athletes could successfully 
complete the test. Östberg et al[19] found 95% of neuro-
logically intact adults completed the task without error, 
while the majority of the remaining participants made a 
single error, with more than one error occurring in less 
than 1% of those tested. Shehata et al[14] found that 
92% of university-level athletes could complete the MBT 
without error. Ettlin et al[27] found that 8/70 patients 
with organic brain lesions made errors (of any type) 
while all 48 neurologically intact subjects completed the 
test without error. Conversely, Jinguji et al[13] reported 
that one third of high school athletes could not complete 
the test, with better completion rates in females and 
those aged 16-19 years compared with 13-15 years. 
The completion time for the MBT differs across 
reports. In a community dwelling population aged 
over 65 years, Ball et al[8] found the MBT duration was 
17 ± 10 s, increasing at four-year follow up to 25 ± 
21 s. Ettlin et al[27] reported task completion times 
of 12.1 ± 11.4 in 48 neurologically intact individuals 
(mean age 40.4 ± 13.8) with much slower completion 
times for patients with frontal (33.1 ± 40.8) and non-
frontal (21.6 ± 12.4) lesions. Ostberg et al[11] reported 
completion times of 9.6 ± 3.1 s in 66 elderly memory 
clinic attenders without identifiable objective cognitive 
impairment. Östberg et al[19] studied 216 neurologically 
intact adults and found a mean time for completion 
of 11.6 ± 5.6 s. Durations varied according to age 
and educational level from 9.0 ± 2.2 in the 30-60 age 
category with greater (third level) educational exposure 
to 16.3 ± 8.1 in over 60 years old who had lower 
educational attainments.
Numerous studies have identified how MBT perfor-
mance varies with age. Östberg et al[19] found that peak 
performance (MB duration) occurred in 30-60 year olds 
compared with younger and older age bands. Ball et al[8] 
found an exponential relationship between advancing 
age and MB duration, both cross-sectionally and 
longitudinally. Jinguji et al[13] found greater completion 
rates amongst 16-19 years old compared to 13-15 
years old. Ostberg et al[11] found a weak association 
between age and MBT but not MFT performance in 
elderly memory clinic attenders. Although some work 
suggests a trend towards better test performance 
in females[13,14], other studies suggest similar MB 
accuracy[20] and MB duration[11,19] for otherwise similar 
male and female subjects.
Psychometric properties 
A key advantage of the MBT is that the universal 
nature of the content allows for excellent coverage, and 
performance can be studied in most patients from a 
variety of populations, including those with significant 
cognitive impairments[11,16]. Because most normal 
elderly (typically > 95% in studies) can complete 
the test without difficulty[19,16], poor performance is 
very suggestive of abnormality. Moreover, the lack of 
reliance on motor or visual abilities reduces the impact 
of disturbances to these functions on performance. 
Ostberg et al[11] found that only 6 of 234 memory clinic 
attendees could not be assessed with the MBT.
The MBT has high concordance with many other 
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  Ryan et al[16] (2013) and 
  O’Regan et al[17] (2014) 
To screen for attention problems in 311 general hospital inpatients 
for further testing regarding possible delirium and dementia 
Pass vs fail according to whether subjects could reach July 
without major error/with minimal prompting
  Tardiff et al[12] (2013) To identify predictors of cognitive decline in patients with 
Alzheimer’s dementia
Pass vs fail according to whether subjects could correctly 
order the months from December to January 
  Bellelli et al[18] (2014) To evaluate a new screening tool for delirium (4AT) in 236 elderly 
medical patients
MBT performance rated as: 
Achieves 7 mo correctly = 0
Refuses or starts but scores < 7 mo = 1
Untestable = 2
MBT: Months backward test; FLS: Frontal Lobe Score; AD: Alzheimer’s disease; AcI: Accuracy index; IVD: Ischemic vascular dementia; NC: Non-demented 
control group; TBI: Traumatic brain injuries; PD: Parkinson’s disease; SCAT: Sport concussion assessment tool.
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cognitive tests, including the digit span backwards[13,29], 
trailmaking test B[29], serial threes and sevens[20], 
delayed story recall (WMS-R) and standardized list 
learning measures[29]. In addition, concurrent validity 
with the MBT has been described for other cognitive 
tests including culture fair Intelligence Quotient (r = 
0.31; P < 0.02)[24], short-blessed test (r = 0.5)[8], 
trailmaking test B (r = 0.45)[8], and tests of simple (r = 
0.52) and complex choice (r = 0.51) reaction time[8].
Test-retest reliability has been examined for both 
“MB accuracy” and “MB duration”. Ball et al[8] found 
MB duration had excellent test-retest reliability (0.90) 
amongst 120 elderly community residents reassessed 
1 wk to 10 d later, suggesting that it is an operationally 
stable measure. Of note, at four-year follow-up, the 
time taken for the MBT had increased considerably 
(as above) emphasising that it can also capture 
deteriorating cognitive function over time. Marinus et 
al[9] examined test-retest reliability (K = 0.44) for MB 
accuracy in 30 patients with Parkinson’s disease after 
a 6 wk interval. Östberg et al[19] found test-retest 
reliability of 0.82 for duration and 0.97 for accuracy in 
40 neurologically intact adults aged 18-80 assessed 
by periods separated by three weeks. The inter-rater 
reliability of the MBT between a neuropsychologist and 
a postdoctoral research fellow in patients with traumatic 
brain injury was high (r = 0.95)[29]. 
Neuropsychological studies
The MBT engages a range of cognitive and perceptual 
faculties including hearing, speech, basic compre-
hension, the ability to focus and sustain attention, 
working memory and executive function. The informa-
tion involved is an automatic word sequence that is 
non-novel and relatively universal - few patients have 
difficulties with the information content as it reflects 
culturally acquired factual knowledge. The basic ability 
to recite MF can be used to test the ability to generate 
automatic speech in patients with dysphasia[30], while 
the MBT requires mental control and sustained attention 
in order to inhibit the impulse to recite the months in a 
forwards direction.
The cognitive processes of attention and working 
memory are often conceptualised within a tripartite 
model[31] where a central executive component controls 
a phonological loop (allowing subvocal rehearsal) and a 
visuospatial sketchpad (facilitating mental visualisation). 
Forwards processing is linked to procedural memory, 
while backwards processing has greater engagement 
of working memory. In addition, backwards processing 
has greater involvement of visuospatial mechanisms[32] 
thought to reflect the role of visual imagery in trans-
forming material into reverse order by, for example, 
visualising the calendar and reading from bottom to 
top. Neuroimaging studies of focal brain lesions and 
positron emission tomography studies of the neural 
elements that appear involved in forwards vs backwards 
processing (using the digit span tests) indicate that 
backwards processing is linked to greater activation 
of the dorsolateral prefrontal cortex bilaterally and 
recruitment of Broca’s area[33]. The degree of activa-
tion increases with increasing task difficulty. Increased 
activation of areas contributing to speech motor per-
formance occurs during reverse rather than forwards 
recitation even though both tasks comprise the same 
words and behavioural data. Moreover, there is typically 
a much higher volume of word production under forward 
testing. This indicates that engagement of these areas 
depends on the degree of automatization rather than on 
production speed of verbal utterances, and demonstrates 
the contribution of Broca’s area to the silent rehearsal 
process under reverse testing[34]. However, other work[32] 
emphasises individual variability in the relative reliance 
upon visuospatial vs subvocal mechanisms in task 
performance, including backwards tests.
Wildgruber et al[34] compared the response of neural 
networks during MF vs MBT using functional magnetic 
resonance imaging. Both tests were associated with 
activation of the left motor cortex, supplementary motor 
area and temporo-parietal junction, while the MBT was 
associated with greater activation of the bilateral middle 
and inferior frontal gyri, the posterior parietal cortex and 
the left anterior cingulate gyrus. These studies indicating 
greater involvement of more complex networks for 
backwards cognitive processing are further supported by 
evidence that tasks involving backwards processing are 
more susceptible to the effects of ageing[11,25].
Use of the MBT in clinical populations
The simplicity and convenience of the MBT has allowed 
its use in a range of clinical scenarios, including some 
which require speed and portability of assessment 
procedures. The MBT has demonstrated utility as a single 
or independent measure and as part of composite testing 
tools. These studies include the use of the MBT in the 
assessment of neurocognitive functioning as relevant to 
the detection of major neuropsychiatric conditions such 
as delirium, dementia and MCI[10,11,12,17,18], assessment 
of concussion[13,14,20], profiling of neurocognitive impair-
ments in organic brain disorders[24,35], assessment 
of Parkinson’s disease[9], prediction of delirium risk 
in surgical patients[5] and medication compliance in 
diabetes[6].  
Early studies in elderly hospitalised patients with 
dementia[10,28] found that the MBT was one of seven 
tests (from a total of 25 tests) that discriminated well 
between different levels of cognitive impairment. 
Subsequent work has confirmed the capacity of the MBT 
to distinguish different levels of cognitive impairment. 
Ostberg et al[11], in a memory clinic population, found 
that MBT accuracy varied according to diagnostic 
category, with impaired performance in Alzheimer’s 
disease (AD) (37.7% correct), while most participants 
with mild cognitive impairment (MCI) or subjective 
cognitive impairment (SCI) performed accurately 
(86.9% and 93.9% correct, respectively). MB duration 
significantly differed for all three groups - the average 
in MCI (19.8 ± 18.2) was twice that of SCI participants 
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(9.6 ± 3.1), and MB duration in mild AD (47.8 ± 32.1) 
was almost five-fold greater than in SCI. MB duration 
had equivalent discriminatory power to the Mini-Mental 
State Examination with superior specificity in the 
diagnosis of MCI. MB duration thus had a sensitivity of 
95.0% in the diagnosis of AD vs SCI, and its specificity 
was 86.5%. Tardiff et al[12] found that MBT scores, 
rather than other tests of cognition (e.g., clock drawing) 
predicted conversion from mild to moderate AD and 
suggest that supplementing the mini mental state 
examination (MMSE) with the MBT can improve the 
predictive value of the MMSE for dementia.
The MBT is a widely-used test for inattention in 
delirium and is recommended for testing attention in the 
Revised Delirium Rating Scale administration manual[36] 
and the 4AT[18]. Rudolph et al[5] studied predictors of 
delirium in elderly patients undergoing cardiac surgery (n 
= 80; mean age 74.9 ± 6.2) and found that failing MBT 
pre-operatively was associated with a relative risk of 
1.63 (1.07-2.49) of post-operative delirium. O’Regan et 
al[17] compared the diagnostic accuracy of the MBT with 
the Spatial Span Forwards, subjective “confusion” and 
objective “confusion’ in a general hospital population 
(n = 265) undergoing screening for inattention as part 
of a point prevalence study of delirium. Overall, ability 
to complete the MBT performed the best in terms of 
combined sensitivity (83.3%; 95%CI: 69.8-92.5) and 
specificity (90.8%; 95%CI: 86.1-94.3) for delirium, 
especially in older patients. Bellelli et al[18] studied 234 
older inpatients and found the MTB demonstrated high 
sensitivity to delirium, at 93% for one error, and 86% 
for two or more errors. Interestingly, the specificity for 
one error was 50% and for two errors was 83%. 
The MBT has also been studied in patients with 
organic brain syndrome (OBS). Wildgruber et al[35] found 
considerably slower completion times and more errors 
in patients with various organic brain lesions compared 
to neurologically intact controls. Also, within the OBS 
group, patients with frontal lobe lesions (determined 
through neuroimaging) had particularly severe impair-
ments in performance compared to those without 
frontal involvement, thus highlighting the relevance of 
frontal lobe mechanisms in MBT performance. Similarly, 
Ettlin et al[27] found that MBT duration distinguished 
patients with organic brain lesions from those without, 
and also those with frontal lesions from those with 
lesions elsewhere. In contrast, Roca et al[24] found 
that performance on the MBT did not distinguish age-
matched controls from patients with carefully docu-
mented chronic focal frontal lesions, but in contrast to 
other studies in OBS patients, performance rating used 
a simple 3 point scale which may have restricted the 
capacity of testing to distinguish these groups. 
The MBT has also been used in studies of concu-
ssion, mainly as part of the standardised assessment 
of concussion (SAC)[37] and the Sports Concussion 
Assessment Tool[38], both of which include a variety of 
tests relevant to detecting concussion. The need for 
baseline values as a comparison point has stimulated 
the collection of data regarding MBT performance in 
younger populations at risk of concussion. The study 
findings contrast in respect of performance - Shehata 
et al[14] found completion (without error) rates of 90% 
or more for all groups studied. In contrast, Schneider 
et al[15] found much lower completion rates amongst 
youth hockey players (aged 9-17), especially in males 
where approximately 50% could complete the MBT at 
baseline. Similarly, Jinguji et al[13] reported completion 
rates of approximately two-thirds of college athletics 
scholarship students. 
Performance on the MBT is significantly poorer in 
patients with Parkinson’s disease compared to controls 
without any history of neurological impairment. As 
a result the MBT is included as one of two tests of 
attention (along with serial threes) in the ten-item 
SCOPA-COG (SCales for Outcomes of PArkinson’s 
disease-COGnition), used to measure the cognitive 
impairments in Parkinson’s disease, including changes 
over time[9]. 
In other work, Grober et al[6] examined factors 
associated with glycaemic control in 169 diabetics 
(median age 74), finding that MBT performance 
independently predicted poor control (HbA1c levels ≥ 7). 
Moreover, the risk of poor control increased with greater 
impairment on MBT performance. They interpreted 
the relationship as bidirectional in causality - cognitive 
dysfunction interfered with diabetes management, and 
inadequate diabetic control contributed to cognitive 
dysfunction.
MBT and neuropsychological test batteries
This paper focuses upon literature that relates speci-
fically to MBT used as an independent measure of 
cognitive function. The MBT is also included in a variety 
of test batteries and, as such, we included findings 
where its use could be identified as separate from other 
tests. These batteries have used the MBT to measure 
attention, concentration, processing speed, automatic 
language generating capacity and mental control. These 
include the Weschler Memory Scale- Mental Control 
Subtest, Short orientation memory and concentration 
test[39], the SCOPA-COG[9], SAC[37], Scat-2[38], Boston 
Diagnostic Aphasia Score[40], Frontal Lobe Score[35], 
the 4AT[18] and the Bangor Dyslexia Test[30]. With the 
increasing interest in the MBT as an independent 
measure, it would be useful for reports of these tools to 
describe the findings in relation to individual elements, 
including the MBT. 
DISCUSSION
The MBT has been used in various clinical settings for 
many decades. During this time, several approaches 
to delivery and interpretation have emerged which 
complicates comparisons across studies. The test has 
significant advantages in terms of brevity and the 
minimal resources required for its delivery, even for 
timed versions, and it is independent of motor and 
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visual function. These together afford potential for the 
test to be used for widespread cognitive screening.
A further advantage relates to the complexity of 
“pitch” of the test such that performance on the MBT 
can be assessed for accuracy and duration in those with 
greater cognitive abilities, thus creating a useful range 
of performance for testing across populations with 
differing levels of cognitive abilities. Performance during 
different phases of the test can provide insights into 
the nature of cognitive deficits, such that errors at the 
beginning of the test suggest problems with focusing 
attention, while errors later in the test indicate problems 
with sustaining attention. 
The MBT can be successfully completed by most 
cognitively intact adults such that difficulties in comple-
ting the test are a sensitive indicator of significant 
cognitive problems. In contrast, the majority of other 
attention tests have been developed for non-delirium 
purposes and are subject to a floor effect, especially in 
those with existing cognitive problems. A key challenge 
within healthcare is to identify tests that are attuned 
or calibrated to the functional range of the target 
population. In many cases (e.g., concussion, delirium) 
this requires so-called “simple-smart” tests, and MBT 
offers this flexibility. 
However, despite its relative simplicity, there 
are considerable inconsistencies in how the MBT is 
conducted and interpreted. Uncertainties regarding 
how to deal with patient errors (e.g., interpretation of 
omissions, commissions, perserverations, stuttering, 
etc.) and the optimal use of verbal and body-language 
to prompt subjects are important potential sources of 
variability in test delivery. Increasing use of computer-
assisted technology[41] and detailed protocolisation of the 
test and its interpretation can minimise these effects.
The choice of the most appropriate version of the 
MBT can be informed by factors such as the age and 
prior cognitive status of the population studied, desire 
to assess attention (or specific aspects of attention) vs 
other aspects of cognition such as central processing 
speed, and availability of a suitable timing device. Based 
upon this review, a suggested scheme for simple and 
more detailed hierarchical MBT performance assessment 
is shown in Table 3. This provides two levels of detail 
for assessing performance - a detailed ten point 
performance score as well as a simple 4 point scale 
where a binary (pass/fail) is distinguished by applying 
the cut off of a pass requiring that the subject completes 
the test without (omission) error within 30 s (if under 65 
years old) or 60 s (if over 65 years old).
The MBT is a versatile tool that can be applied 
across a variety of populations, including those with 
significant cognitive and other functional impairment. 
It is brief, easy to explain and administer, requires 
minimal resources, focuses upon automatic pre-existing 
knowledge, has good coverage of clinical populations, 
and can assess a range of functions from attention 
to central processing speed. Greater consistency 
in its application - both in respect of administration 
and evaluation can allow for more widespread use 
in a variety of clinical circumstances. The increasing 
application of computerised technologies can also 
improve the consistency of use. Greater work is needed 
to ascertain the extent to which the MBT can act as an 
independent tool and in which situations it should be 
combined with other assessments. The complexity of 
the test varies considerably according to whether it is 
evaluated in respect of ability to complete, accuracy or 
duration. The increasing use of routine and systematic 
cognitive testing in clinical environments creates a need 
for brief and efficient methods for formalised testing. The 
MBT has many characteristics that make it an attractive 
option in this regard, both for cognitive screening and 
for assessing the character of impairment where it is 
present.  
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Background
Efficient bedside testing of cognition is crucial to improving detection of a range 
of important and common neuropsychiatric conditions. A variety of tests are 
available but their actual utility and accuracy in real world practice is uncertain. 
The months backward test (MBT) is a simple and popular test of attention 
and other faculties. The authors reviewed the available evidence regarding its 
optimal use in research and real world clinical practice.
Research frontiers
A key challenge in cognitive neuroscience is to identify a suitable test for use 
as a cognitive “vital sign”. However, there is a lack of consensus regarding the 
most versatile tests which is in part due to a lack of clear evidence regarding 
the optimal use of available tests in clinical practice. This work examines the 
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Table 3  Suggested grading of performance on the months 
backward test
  Simple grading: 
     0 = The subject cannot engage meaningfully with testing procedures
     1 = The subject engages but cannot complete the test, even with 
     prompting
     2 = The subject completes the test, but with prompting and/or errors
     3 = The subject completes the test without error within 30 s (under 65 
     years old) or 60 s (over 65 years old)
  Detailed grading (e.g., for research)
     0 The subject does not understand that they are being assessed? i.e., 
     lacking basic awareness 
     1 The subject understands that they are being assessed
     2 The subject understands the “rules” of the test (i.e., can grasp/
     comprehend the test) 
     3 The subject engages with testing procedures, e.g., recite months      
     forward (i.e., focused attention)
     4 The subject engages in a sustained manner, i.e., sustained attention
     5 The subject successfully shifts to backwards testing, i.e., shift attention
     6 The subject can reach July 
     7 The subject can reach January
     8 If the subject makes any errors, they recognise this and/or try to 
     correct the errors 
     9 The subject completes the test without errors 
     10 Completion of the test takes less than 90 s/60 s/30 s
 COMMENTS
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characteristics of the MBT that inform its suitability for routine and systematic 
bedside cognitive screening in clinical settings.
Innovations and breakthroughs
This review explores evidence regarding a broad range of characteristics 
that are relevant to the use of the MBT as a cognitive test in everyday clinical 
practice with emphasis upon its suitability for rapid, routine and repeated 
use by a variety of healthcare professionals in a various clinical populations. 
The authors found that the MBT is a highly versatile test and have developed 
guidelines that can support greater consistency in its administration and 
interpretation.
Applications
The authors have distilled the findings into a set of guidelines that can allow for 
more consistent application of the MBT in clinical and research practice. This 
will allow for greater consistency across research studies.
Terminology
Psychometric properties of a test relate to its ability to measure what is intended 
as well as the capacity to capture this consistently over time and by different 
assessors.
Peer-review
The manuscript entitled “Months backward test: A review of its use in clinical 
studies” is a straightforward and well-writtten review dealing with a highly 
intriguing cognitive test.
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